These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23891772)

  • 1. Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model.
    Dilnawaz F; Sahoo SK
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):452-62. PubMed ID: 23891772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
    Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide-Mediated Apoptotic Death Is Improved by Thymoquinone in U87MG Cell Line.
    Khazaei M; Pazhouhi M
    Cancer Invest; 2017 Apr; 35(4):225-236. PubMed ID: 28355088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
    Kundu P; Mohanty C; Sahoo SK
    Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
    Ramachandran C; Nair SM; Escalon E; Melnick SJ
    J Complement Integr Med; 2012 Aug; 9():Article 20. PubMed ID: 22944718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
    Gokturk D; Kelebek H; Ceylan S; Yilmaz DM
    Turk Neurosurg; 2018; 28(1):13-18. PubMed ID: 28191621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micelle-assisted combination therapies for effective glioblastoma treatment: an in-vitro assessment.
    Mohanty AK; Mohanta GP
    Anticancer Drugs; 2015 Mar; 26(3):312-22. PubMed ID: 25462134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.
    Atif F; Patel NR; Yousuf S; Stein DG
    PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling.
    Yin H; Zhou Y; Wen C; Zhou C; Zhang W; Hu X; Wang L; You C; Shao J
    Oncol Rep; 2014 Oct; 32(4):1610-6. PubMed ID: 25050915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide.
    Cui Y; Naz A; Thompson DH; Irudayaraj J
    Mol Pharm; 2015 Apr; 12(4):1279-88. PubMed ID: 25751281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
    Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
    Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells.
    Serafino A; Krasnowska EK; Romanò S; De Gregorio A; Colone M; Dupuis ML; Bonucci M; Ravagnan G; Stringaro A; Fuggetta MP
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
    Manju S; Sreenivasan K
    Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
    Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.
    Bertucci A; Prasetyanto EA; Septiadi D; Manicardi A; Brognara E; Gambari R; Corradini R; De Cola L
    Small; 2015 Nov; 11(42):5687-95. PubMed ID: 26395266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
    Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
    Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
    Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J
    Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line.
    Josset E; Burckel H; Noël G; Bischoff P
    Anticancer Res; 2013 May; 33(5):1845-51. PubMed ID: 23645729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.